Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

MacRae F. Linton, James B. Atkinson, Sergio Fazio

    Research output: Contribution to journalArticle

    393 Scopus citations


    Apolipoprotein E (apoE) deficiency causes severe hyperlipidemia and atherosclerosis in humans and in gene-targeted mice. Although the majority of apoE in plasma is of hepatic origin, apoE is synthesized by a variety of cell types, including macrophages. Because macrophages derive from hematopoietic cells, bone marrow transplantation was used to examine the potential of apoE synthesized by bone marrow-derived cells to correct the hyperlipidemia and atherosclerosis caused by apoE deficiency. After transplantation of bone marrow from mice with the normal apoE gene into apoE-deficient mice, apoE was detected in serum and promoted clearance of lipoproteins and normalization of serum cholesterol levels. ApoE-deficient mice given transplants of normal bone marrow showed virtually complete protection from diet-induced atherosclerosis.

    Original languageEnglish (US)
    Pages (from-to)1034-1037
    Number of pages4
    Issue number5200
    StatePublished - Jan 1 1995

    ASJC Scopus subject areas

    • General

    Fingerprint Dive into the research topics of 'Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation'. Together they form a unique fingerprint.

  • Cite this